¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-13
±³À°ÀÏÀÚ : 2022-05-13
±³À°Àå¼Ò : ´õ ¸ÞÀÌ È£ÅÚ(ÀüºÏ ÀüÁÖ)  
±³À°ÁÖÁ¦ : 2022³â Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ
´ã´çÀÚ : ÃÖÇýÁø
¿¬¶ôó : 02-743-6574  
À̸ÞÀÏ : kosro@kosro.or.kr      
±³À°Á¾·ù : ¹æ»ç¼±Á¾¾çÇаú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡   (ÀÏ¹Ý 1Á¡ / Çʼö 2Á¡)  
Áö¿ª : Àü¶óºÏµµ
±³À°½Ã°£ : 3 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í ¿ø·Îȸ¿ø:¹«·á Á¤È¸¿ø(Àü¹®ÀÇ) : 100,000 Á¤È¸¿ø(±ºÀÇ°ü,°øº¸ÀÇ) : 100,000¿ø ¼ö·Ãȸ¿ø : 50,000¿ø Ưº°È¸¿ø(ÀÇÇй°¸®/»ý¹°¹Ú»ç) :70,000¿ø ÁØȸ¿ø : 40,000¿ø Çлý(ºñȸ¿ø) :30,000¿ø ºñȸ¿ø : 120,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
½Ä»ç 05-13 ½Ä´ç 12:00~13:00 Luncheon symposium  À§Âù¿ì(¼­¿ïº¸¶ó¸Åº´¿ø) 
±âŸ 05-13 ±×·£µåº¼·ë 13:00~13:10 Welcome address  ¿ìÈ«±Õ(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 13:10~14:00 Keynote lecture: Assessment of Simulated COVID-19 Infection and Mortality Risk Associated with Radiation Therapy  Rifaquat Rahman(Harvard Medical School) 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 14:00~14:25 review 1: head & neck, lung  ¹®¼ºÈ£(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 14:25~14:50 review 2: breast, GI  ±è±Ôº¸(ÀÌ´ë¸ñµ¿º´¿ø) 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 14:50~15:15 review 3: GY, GU  ±è¿µ¼®(¼­¿ï¾Æ»êº´¿ø) 
È޽Ġ05-13 ±×·£µåº¼·ë 15:15~15:45 È޽Ġ () 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 15:45~16:10 Heal our patients  ¹ÚÇýÀ±(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 05-13 ±×·£µåº¼·ë 16:10~16:50 Heal ourselves  ±è°æÀÏ(¾ÆÁÖ´ëÇб³º´¿ø) 
±âŸ 05-13 ±×·£µåº¼·ë 16:50~17:00 ROJ awards ½Ã»ó  À±»ó¹Î(¼­¿ï¾Æ»êº´¿ø) 
±âŸ 05-13 ±×·£µåº¼·ë 17:00~17:20 ROJ award lecture (distinguished ROJ paper)  À±»ó¹Î(¼­¿ï¾Æ»êº´¿ø) 
±âŸ 05-13 ±×·£µåº¼·ë 17:20~17:30 Closing remark  ¿ìÈ«±Õ(¼­¿ï´ëÇб³º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â Ãá°èÇмú´ëȸ : 2022-05-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦56ȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2022-05-14
´ÙÀ½±Û ´ëÇÑÀ忬±¸ÇÐȸ The 5th International Meeting on Intestinal Diseases in Conjunction with the Annual Congress of KASID (IMKASID 2022)_1ÀÏÂ÷ : 2022-05-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
497 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 KYUNG HEE SHOULDER SYMPOSIUM : 2018-09-08 0 1,517 2018-08-22
496 ´ë±¸ °æºÏ´ëÇб³º´¿ø Á¦ 3Â÷ °³¿øÀǸ¦ À§ÇÑ ´ëÇѺÎÁ¤¸ÆÇÐȸ ¿¬¼ö±³À° : 2018-09-07 0 749 2018-08-22
495 °­¿ø ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø NAFLD(non-alcoholic fatty liver disease) and Cardiometabolic Syndrome [7th Gangwon Heart Seminar 2018] : 2018-09-07 0 922 2018-08-22
494 ÀüºÏ ÀüÁÖ ¿¹¼öº´¿ø ´ëÇÑÀçÈ°ÀÇÇÐȸ È£³²Á¦ÁÖÁöȸ ÀçÈ° ½ÉÆ÷Áö¾ö : 2018-09-07 0 1,040 2018-08-22
493 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-07 0 850 2018-08-22
492 ¼­¿ï 2018³â °³¿øÀǸ¦ À§ÇÑ °­µ¿°æÈñ´ëÇб³º´¿ø ¼ÒÈ­±âÁúȯ ¿¬¼ö°­Á : 2018-09-06 0 683 2018-08-22
491 Ãæ³² ´Ü±¹´ëÇб³º´¿ø 2018³â Á¦3Â÷ ´ëÇѺ´¸®ÇÐȸ ´ëÀü¤ýÃæûÁöȸ: ÃÖ½ÅÀÇÇÐÁ¤º¸ Ư°­ ¹× º´¸®ÇÐ Áõ·Ê ¹ßÇ¥ : 2018-09-06 0 769 2018-08-22
490 ´ë±¸ ´ëÇѽŻý¾ÆÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 992 2018-08-22
489 Àü³² Á¦257Â÷ ´ëÇѳ»°úÇÐȸ ±¤ÁÖÀü³²Áöȸ Çмú´ëȸ : 2018-09-06 0 574 2018-08-22
488 °æ³² ´ëÇÑÇǺΰúÇÐȸ º£Ã¼Æ®º´ÀÇ ÃÖ½ÅÁö°ß¿¡ °üÇÏ¿© : 2018-09-06 0 717 2018-08-22
487 Ãæ³² °Ç¾ç´ëÇб³º´¿ø ´ëÇÑÇǺΰúÇÐȸ ÃæûÁöºÎÇÐȸ : 2018-09-06 0 897 2018-08-22
486 ´ë±¸ °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Á¦234Â÷ °æºÏÁöȸ Áý´ãȸ : 2018-09-06 0 742 2018-08-22
485 °æ±â °¡Å縯´ëÇб³ ºÎõ¼º¸ðº´¿ø ´ëÇѺñ´¢±â°úÇÐȸ 2018 Á¦ 3Â÷ ÀÎõ.°æ±âÁöȸ Áý´ãȸ : 2018-09-06 2 1,475 2018-08-22
484 °æ³² ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2018³âµµ 3Â÷ ºÎ»ê¿ï»ê°æ³² ÈäºÎ¿Ü°ú Áý´ãȸ ¹× °­¿¬ : 2018-09-06 0 695 2018-08-22
483 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-06 0 532 2018-08-22
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷